Exact Mass: 391.1202

Exact Mass Matches: 391.1202

Found 47 metabolites which its exact mass value is equals to given mass value 391.1202, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Glycoperine

(2S,3R,4R,5R,6S)-2-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-6-methyl-tetrahydropyran-3,4,5-triol

C19H21NO8 (391.1267)


Glycoperine is an organonitrogen heterocyclic compound, an organic heterotricyclic compound and an oxacycle. Glycoperine is a natural product found in Haplophyllum acutifolium and Haplophyllum latifolium with data available.

   

Chlorohaloperidol

1-(3-(4-Chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine hydrochloride

C21H23Cl2NO2 (391.1106)


   

Zidebactam

(1R,2S,5R)-7-oxo-2-(2-((R)-Piperidine-3-carbonyl)hydrazinecarbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate

C13H21N5O7S (391.1162)


   

Clethodim Sulfone

Clethodim Sulfone

C17H26ClNO5S (391.122)


   
   

Fmoc-Phg(4-F)-OH

Fmoc-Phg(4-F)-OH

C23H18FNO4 (391.122)


   
   
   
   

(S)-2-((S)-2-((S)-2-Amino-4-carboxybutanamido)-4-carboxybutanamido)succinic acid

(S)-2-((S)-2-((S)-2-Amino-4-carboxybutanamido)-4-carboxybutanamido)succinic acid

C14H21N3O10 (391.1227)


   

GLYCOPERINE

NCGC00160235-01!GLYCOPERINE

C19H21NO8 (391.1267)


   

Glycoperine

Glycoperine

C19H21NO8 (391.1267)


Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids

   

PharmaGSID_47330

PharmaGSID_47330

C21H15F2N5O (391.1245)


CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8922; ORIGINAL_PRECURSOR_SCAN_NO 8921 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8944; ORIGINAL_PRECURSOR_SCAN_NO 8942 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8967; ORIGINAL_PRECURSOR_SCAN_NO 8965 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8982; ORIGINAL_PRECURSOR_SCAN_NO 8980 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8963; ORIGINAL_PRECURSOR_SCAN_NO 8961 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8988; ORIGINAL_PRECURSOR_SCAN_NO 8987

   
   

His-Asn-OH

(S)-2-(3-(2-(1H-imidazol-4-yl)ethoxy)-4-nitrobenzamido)-5-amino-5-oxopentanoic acid

C16H17N5O7 (391.1128)


   

Thiazolidine, 3-[(4-butoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

Thiazolidine, 3-[(4-butoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C20H25NO3S2 (391.1276)


   

Rabeprazole Sulfone N-Oxide

Rabeprazole Sulfone N-Oxide

C18H21N3O5S (391.1202)


   

(R)-N-FMOC-4-FLUOROPHENYLGLYCINE

(R)-N-FMOC-4-FLUOROPHENYLGLYCINE

C23H18FNO4 (391.122)


   

2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy-

2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy-

C20H22ClNO5 (391.1186)


   

(S)-(3-(3,4-DICHLOROPHENYL)-3-(3-HYDROXYPROPYL)PIPERIDIN-1-YL)(PHENYL)METHANONE

(S)-(3-(3,4-DICHLOROPHENYL)-3-(3-HYDROXYPROPYL)PIPERIDIN-1-YL)(PHENYL)METHANONE

C21H23Cl2NO2 (391.1106)


   

Amodiaquine dihydrochloride

Amodiaquine dihydrochloride

C20H23Cl2N3O (391.1218)


   

N-(3-NITRO-2-PYRIDINESULFENYL)-O-T-BUTYL-L-TYROSINE

N-(3-NITRO-2-PYRIDINESULFENYL)-O-T-BUTYL-L-TYROSINE

C18H21N3O5S (391.1202)


   

Zidebactam

Zidebactam

C13H21N5O7S (391.1162)


C254 - Anti-Infective Agent > C258 - Antibiotic

   

5-Hydroxy-clethodiM Sulfoxide

5-Hydroxy-clethodiM Sulfoxide

C17H26ClNO5S (391.122)


   

tert-butyl 2-methyl-2-(5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,2-dihydrothieno[2,3-d]pyrimidin-3(4H)-yl)propanoate

tert-butyl 2-methyl-2-(5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,2-dihydrothieno[2,3-d]pyrimidin-3(4H)-yl)propanoate

C18H21N3O5S (391.1202)


   

5-ETHYL-5 6-DIHYDRO-3 8-DINITRO-6-PHENY&

5-ETHYL-5 6-DIHYDRO-3 8-DINITRO-6-PHENY&

C21H17N3O5 (391.1168)


   

(5-acetamido-3,4-diacetyloxy-6-ethylsulfanyloxan-2-yl)methyl acetate

(5-acetamido-3,4-diacetyloxy-6-ethylsulfanyloxan-2-yl)methyl acetate

C16H25NO8S (391.1301)


   
   

N-SUCCINYL-GLY-GLY-GLY P-NITROANILIDE

N-SUCCINYL-GLY-GLY-GLY P-NITROANILIDE

C16H17N5O7 (391.1128)


   

Tavapadon

Tavapadon

C19H16F3N3O3 (391.1144)


C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist (Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, EC50=0.8 nM; β-arrestin2, EC50=68 nM). (Rac)-Tavapadon has antiparkinsonian activity[1]. Tavapadon (PF-06649751) is an orally active and highly selective dopamine D1/D5 receptor partial agonist. Tavapadon is effective in enabling movement and reducing disability and has the potential for Parkinson's disease[1].

   

Tetramethyl 7,9-dimethyl-9aH-quinolizine-1,2,3,4-tetracarboxylate

Tetramethyl 7,9-dimethyl-9aH-quinolizine-1,2,3,4-tetracarboxylate

C19H21NO8 (391.1267)


   
   

Unii-gmy695BP6Q

Unii-gmy695BP6Q

C21H15F2N5O (391.1245)


TPA-023B is a high-affinity and orally active GABAA receptor α2/α3 subtype (Kis of 0.73 nM/2 nM) partial agonist and a α1 subtype (Ki of 1.8 nM) antagonist. TPA-023B has non-sedating anxiolytic-like properties[1].

   

4,8-dimethoxyfuro[2,3-b]quinolin-7-yl 6-deoxy-beta-D-allopyranoside

4,8-dimethoxyfuro[2,3-b]quinolin-7-yl 6-deoxy-beta-D-allopyranoside

C19H21NO8 (391.1267)


   
   
   
   

(2R,3S,4S,5S,6R)-2-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-6-methyloxane-3,4,5-triol

(2R,3S,4S,5S,6R)-2-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-6-methyloxane-3,4,5-triol

C19H21NO8 (391.1267)


   
   

2-hydroxy-2-[(1s,10r,11r,13s)-7-hydroxy-5-methoxy-2,9-dioxo-11-propyl-12,15-dioxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-13-yl]ethanimidic acid

2-hydroxy-2-[(1s,10r,11r,13s)-7-hydroxy-5-methoxy-2,9-dioxo-11-propyl-12,15-dioxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-13-yl]ethanimidic acid

C19H21NO8 (391.1267)


   

2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-methyloxane-3,4,5-triol

2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-methyloxane-3,4,5-triol

C19H21NO8 (391.1267)


   

n-(7-methyl-1,4-dioxo-6-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}naphthalen-2-yl)ethanimidic acid

n-(7-methyl-1,4-dioxo-6-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}naphthalen-2-yl)ethanimidic acid

C19H21NO8 (391.1267)


   

n-(2-{[2-hydroxy-6-(methoxycarbonyl)phenyl]-c-hydroxycarbonimidoyl}phenyl)pyridine-3-carboximidic acid

n-(2-{[2-hydroxy-6-(methoxycarbonyl)phenyl]-c-hydroxycarbonimidoyl}phenyl)pyridine-3-carboximidic acid

C21H17N3O5 (391.1168)


   

n-{7-methyl-1,4-dioxo-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]naphthalen-2-yl}ethanimidic acid

n-{7-methyl-1,4-dioxo-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]naphthalen-2-yl}ethanimidic acid

C19H21NO8 (391.1267)


   

1,2-bis({4-[(1e,3e)-4-carboxybuta-1,3-dien-1-yl]phenyl})-1-hydroxydiazenium

1,2-bis({4-[(1e,3e)-4-carboxybuta-1,3-dien-1-yl]phenyl})-1-hydroxydiazenium

[C22H19N2O5]+ (391.1294)


   

(2s,3s,4r,5r,6s)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-methyloxane-3,4,5-triol

(2s,3s,4r,5r,6s)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-methyloxane-3,4,5-triol

C19H21NO8 (391.1267)


   

n-(2-hydroxy-5-{[8-(hydroxymethyl)-3-oxophenoxazin-2-yl]amino}phenyl)ethanimidic acid

n-(2-hydroxy-5-{[8-(hydroxymethyl)-3-oxophenoxazin-2-yl]amino}phenyl)ethanimidic acid

C21H17N3O5 (391.1168)